MTOR and hypertrophy: In the cardiovascular system, excessively high O‐GlcNAcylation can promote HF by activating the mTOR pathway or induce ventricular cardiomyocyte hypertrophy through PKA pathway activation, significantly exacerbating cardiovascular pathology.